InvestorsHub Logo
Followers 273
Posts 8598
Boards Moderated 0
Alias Born 10/05/2010

Re: DanguardAce post# 395

Sunday, 07/18/2021 7:30:33 AM

Sunday, July 18, 2021 7:30:33 AM

Post# of 4946
No that's it, once the 8K is released showing the RTO is complete, and the terms of the merger are described, then INSD will cease being a shell company, and will become Instadose(private corp).

The stock will continue to trade as it is now......but hopefully with much more volume, however, there is no way of knowing how Grants current situation will affect that, I'd imagine that will hurt us to some degree....how much remains to be seen.

After merger is complete, Instadose should probably move off the 'stinky' Pink Sheets, which is the bottom of the barrel of OTC Market tiers, to at least the OTCQB. The OTCQX is their highest tier and has by far the most disclosure and transparency, this could be an option, it's generally considered a stepping stone to the Big Boards, whether it's worth the additional fees, is debatable though.

OTC traders don't care one way or the other about these (3) OTC tiers.....but actual investors, institutional investors, and the regulators might.

As far as uplisting goes, these are the requirements for NASDAQ. I'd assume they will likely meet the requirements for at least their small cap market but they may wait and see how Grants situation plays out first. So I'm anticipating at least 7 months minimum on the OTC, probably more like 1 - 2 years though realistically. That's why the OTCQX would not be a bad option, similar to CURLF....JMHO.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=156730871